Download PDF
TumorDiagnostik & Therapie 2008; 29(2): 91-95
DOI: 10.1055/s-2008-1027323
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Dilemmas in Therapy of Gestational Breast Cancer: Review of Literature

Dilemma in der Therapie bei Schwangeren mit Brustkrebs: Übersicht der LiteraturJ. Fajdić1 , N. Gotovac2 , Z. Hrgović3
  • 1Department of Surgery, County Hospital, Pozega, Croatia
  • 2Department of Radiology, County Hospital, Pozega, Croatia
  • 3Department of Obstetrics and Gynecology, J. J. Strossmayer University, Clinical Hospital Osijek, Croatia
Further Information

Publication History

Publication Date:
18 April 2008 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Gegenstand: Unter Verwendung von meist rückblickenden/retrospektiven Studien und diverser anderer verfügbarer Publikationen ist das Ziel dieser Besprechung/dieses Reviews aufzuzeigen, dass es neben den meisten geklärten Problemen noch verschiedene Unklarheiten bezüglich der GBC-Behandlung (Behandlung von Brustkrebs in der Schwangerschaft) gibt. Ergebnisse: Die Mehrheit der verwendeten Publikationen stellen klare Positionen im Hinblick auf die chirurgische Behandlung von GBC dar, wobei eine modifizierte radikale Brustamputation in diesen Präsentationen vorherrscht - unabhängig vom Stadium der Krankheit oder der Schwangerschaft. Aber es gibt Möglichkeiten der Anwendung von brusterhaltenden Eingriffen in Fällen mit einem geringeren Erkrankungsstadium, wenn postoperative Bestrahlung angewendet wird. Soweit die Strahlentherapie bei GBC angewendet wird, hat die Mehrheit der Autorenprotokolle ein klares Verständnis über die Risiken, die die Bestrahlung für den Fötus mit sich bringt und wie das Risiko im Hinblick auf das Stadium der Schwangerschaft bzw. im Hinblick auf die Entwicklung des Fötus zu analysieren ist. Zweifellos sind im ersten Trimester, während der Einnistung in den ersten zehn Tagen und während der Entwicklung der Organe, die zerstörenden Effekte der Bestrahlung am höchsten. Der Erfolg und die eingesetzten Modelle bei der Chemotherapie gegen GBC sind ebenso abhängig vom Stadium der Schwangerschaft. In allen Publikationen ist klar herausgestellt, dass die Chemotherapie im ersten Trimester der Schwangerschaft wegen allen neuro- und kardiotoxischen Effekten und der beträchtlichen Verzögerung des Wachstums des Fötus nicht akzeptabel ist. Wenn die Chemotherapie im dritten Trimester benötigt wird, kann sie auf den Zeitpunkt nach der Entbindung verzögert werden. Es besteht heutzutage Konsens dahingehend, dass der therapeutische Abort vermieden werden sollte - außer in klar definierten Fällen von GBC. Zusammenfassung: Das größte Problem im Hinblick auf die Festlegung der multidisziplinären Behandlung von GBC ist die kleine Anzahl von vorausblickenden/prospektiven Studien, während retrospektive Studien auf lange zeitliche Perioden der Beobachtung nach der Behandlung von GBC sowie der Behandlung durch mehrere Ärzte und der Verwendung von manchmal verschiedenen Behandlungsansätzen basieren. Es bleibt zu sagen, dass die Literatur heutzutage zeigt, dass das Stadium der Schwangerschaft bzw. das Alter des Fetus das grundlegende Kriterium für jegliche Art von Behandlung von GBC ist.

Abstract

Purpose: Goal of this review is, by using data of mostly retrospective studies and other available publications, to point out that besides most of cleared problems, there are several dilemmas in GBC treatment. Patients and methods: Reviewing protocols using Medline database as well as conclusions from meetings specialized on this topic, we found that greatest problems are in chemotherapy and irradiation of patients in I. and II. trimester. Problems in surgical part of treatment are considerably smaller. Results: Majority of used publications bring us clear positions about surgical treatment of GBC where modified radical mastectomy is prevailing, regardless to stage of disease or pregnancy. But, there are possibilities for usage of breast conserving surgery in cases with lower grade of the disease, if postoperative irradiation is used. As far as radiotherapy of GBC is used, majority of protocols consider clear understanding of risks that radiation carries for the fetus, and how the risk is to be analyzed considering stage of pregnancy, or in other words, stage of fetal development. Without doubt, highest level of deletory effects of radiation is in first trimester, during implantation in first ten days, and after, during organogenesis. Success and models used in chemotherapy in GBC is also dependable on stage of the pregnancy. All publications state clearly that chemotherapy is not acceptable in first trimester of pregnancy, due to all neuro and cardio toxic effects and considerable growth retardation. If needed during third trimester, chemotherapy can be delayed after delivery. There is consensus today that therapeutic abortion is to be avoided, except clearly defined cases of GBC. Conclusion: Biggest problem in getting the multidisciplinary treatment of GBC more clear is small number of prospective studies, while retrospective studies are based on tracking the patients after long periods after the treatment of GBC as well as patients treated by several physicians and using sometimes different approaches. It still remains to be said, literature shows today that stage of pregnancy, or in other words, age of fetus, is base criteria for any kind of treatment of GBC.

Schlüsselwörter

Schwangerschaftsbrustkrebs - therapeutische Schwierigkeiten/Dilemma - Literaturangaben

Key words

gestational breast cancer - dilemmas in therapy - review of literature

References

  • 1 Nugent P, O’Connell T X. Breast cancer and pregnancy.  Arch Surg. 1985;  120 1221-1224
    Google Scholar
  • 2 Applewhite R R, Smith L R, De Vincenti F. Carcinoma of the breast associated with pregnancy and lactation.  Am Surg. 1973;  39 101-104
    Google Scholar
  • 3 Treves N, Holleb A I. report of 549 cases of breast cancer in women 35 years of age or younger.  Gynecol Obstet. 1958;  107 271
    Google Scholar
  • 4 Bauerfeind I, Lenhard M, Kahlert S. et al . Review: breast cancer and pregnancy.  Eur Clin Obste & Gynec. 2005;  1 (No 2) 95-101
    Google Scholar
  • 5 Merviel P, Salat-Baroux J, Uzan S. Cancer du sein au cours dela grossesse.  Bull Cancer. 1996;  83 266-175
    Google Scholar
  • 6 Haagensen C D, Stout A P. Carcinoma of the breast. Criteria for operability.  Ann Surg. 1943;  118 859-870
    Google Scholar
  • 7 Epstein R J. Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care.  MBC Cancer. 2007;  7 92
    Google Scholar
  • 8 Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review.  Breast Cancer Res Treat. 2007;  (Epub ahead of print)
    Google Scholar
  • 9 Partridge A H, Lesnikoski B A, Burstein H J. Treatment of breast cancer during pregnancy. Summary Expert Opinion on Pharmacotherapy.  Expert Opinion. 2002;  3 (4) 423-428
    Google Scholar
  • 10 Puckridge P J, Saunders C M, Ives A D. et al . Breast cancer and pregnancy: A diagnostic and management dilemma.  ANZ J Surg. 2003;  73 500-503
    Google Scholar
  • 11 Saunders C, Hickey M, Ives A. Breast Cancer During Pregnancy.  Int J Fertil. 2004;  49 (5) 1-5
    Google Scholar
  • 12 Gemignani M L, Petrek J A, Borgen P I. Breast cancer and pregnancy.  Surg Clin North Am. 1999;  79 1157-1169
    Google Scholar
  • 13 Fajdić J. Rak dojke tijekom trudnoće i dojenja. U: Deveti znanstveni sastanak bolesti dojke, Zbornik radova Zagreb; HAZU 1999: 55-65
    Google Scholar
  • 14 Melnick D M, Wahl W L, Dalton V K. Management of general surgical problems in the pregnant patient.  Am J Surg. 2004;  187 170-180
    Google Scholar
  • 15 Hoover H. Breast cancer during pregnancy and lactation.  Surg Clin North Am. 1990;  70 1151-1163
    Google Scholar
  • 16 Kuerer H M, Gwyn K, Ames F C. et al . Conservative surgery and chemotherapy for breast carcinoma during pregnancy.  Surgery. 2002;  131 108-110
    Google Scholar
  • 17 Psyrri A, Burtness B. Pregnancy-Associated Breast cancer.  Cancer J. 2005;  11 83-95
    Google Scholar
  • 18 Keleher A J, Theriault R L, Gwyn K M. et al . Multidisciplinary management of breast cancer concurrent with pregnancy.  J Am Coll Surg. 2001;  194 54-64
    Google Scholar
  • 19 Gwyn K, Theriault R. Breast cancer during pregnancy.  Oncology. 2001;  15 39-46
    Google Scholar
  • 20 D’Ercole F J, Scott D, Bell E. et al . Paravertebral blockade for modified radical mastectomy in a pregnant patient.  Anesth Analg. 1999;  88 1351-1353
    Google Scholar
  • 21 Mazze R I, Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases.  Am J Obstet Gynecol. 1989;  161 1178-1185
    Google Scholar
  • 22 Petrek J A. Breast cancer during pregnancy.  Cancer. 1994;  74 518-527
    Google Scholar
  • 23 Hill M A, Albert T, Zieske A. et al . Successful resection of multifocal hepatic adenoma during pregnancy.  South Med J. 1997;  90 357-361
    Google Scholar
  • 24 Terkivatan T, De Wilt J HW, deMan R A. et al . Management of hepatocellular adenoma during pregnancy.  Liver. 2000;  20 186-187
    Google Scholar
  • 25 Brunt L M. Phaeochromocytoma in pregnancy.  Br J Surg. 2001;  88 481-483
    Google Scholar
  • 26 Dave S P, Reis E D, Hossain A. et al . Splenic artery aneurysm in the 1990s.  Ann Vasc Surg. 2000;  14 223-229
    Google Scholar
  • 27 Caillouette J C, Merchant E B. Ruptured splenic artery aneurysm in pregnancy: twelfth reported case with maternal and fetal survival.  Am J Obstet Gynecol. 1993;  168 1810-1813
    Google Scholar
  • 28 Saunders C M, Baum M. Breast cancer and pregnancy: a review.  J R Soc Med. 1993;  86 162-165
    Google Scholar
  • 29 Doll D C, Ringeberg Q S, Yarbro J W. Management of cancer during pregnancy.  Arch Intern Med. 1988;  148 2058-2064
    Google Scholar
  • 30 Hubay C A, Barry F M, Marr C C. Pregnancy and breast cancer.  Surg Clin North Am. 1978;  58 819-831
    Google Scholar
  • 31 Jablon S, Kato H. Childhood cancer in relation to prenatal exposure to atomic-bomb radiation.  Lancet. 1970;  2 1000-1003
    Google Scholar
  • 32 MacMahon B. Prenatal x-ray exposure and childhood cancer.  J Natl Cancer Inst. 1962;  28 1173-1191
    Google Scholar
  • 33 Gustavson K H, Jagell S, Blomquist H K. et al . Microcephaly mental retardation and chromosomal aberrations in a girl following radiation therapy during late fetal life.  Acta Radiol Oncol. 1981;  20 209-212
    Google Scholar
  • 34 Bloom A D, Neriishi S, Kamada N. et al . Cytogenetic investigation of survivors of the atomic bombings of Hiroshima and Nagasaki.  Lancet. 1966;  2 672-674
    Google Scholar
  • 35 Stewart A, Kneale G W. Radiation dose effects in relation to obstetric x-rays and childhood cancers.  Lancet. 1970;  1 1185-1188
    Google Scholar
  • 36 Court-Brown W M, Doll R, Hill R B. Incidence of leukemia after exposure to diagnostic radiation in utero.  Br Med J. 1960;  2 1539-1545
    Google Scholar
  • 37 Ricoul M, Dutrillaux B. Chromosome hyper-radiosensitivity in mice at the end of pregnancy.  C R Acad Sci III. 1991;  312 635-639
    Google Scholar
  • 38 Wood J W, Johnson K G, Omori Y. et al . mental retardation in children exposed in utero to the atomic bombs in Hiroshima and Nagasaki.  A J Public Health Nations Health. 1967;  57 1381-1389
    Google Scholar
  • 39 Otake M, Schull W J. In utero exposure to A-bomb radiation and mental retardation: a reassessment.  Br J Radiol. 1984;  57 409-414
    Google Scholar
  • 40 Tabuchi A, Nakagawa S, Hirai T. et al . Fetal hazards due to x-ray diagnosis during pregnancy.  Hiroshima J Med Sci. 1967;  16 49-66
    Google Scholar
  • 41 Van der Vange N, Dongen van J. Breast cancer and pregnancy.  Eur J Surg Oncol. 1991;  17 1-8
    Google Scholar
  • 42 Tralins A H. Lactation after conservative breast surgery combined with radiation therapy.  Am J Clin Oncol. 1995;  18 40-43
    Google Scholar
  • 43 Doll D C, Ringenberg Q S, Yarbro J W. Antineoplastic agents and pregnancy.  Semin Oncol. 1989;  16 337-346
    Google Scholar
  • 44 Bawle E V, Conard J V, Weiss L. Adult and two children with fetal methotrexate syndrome.  Teratology. 1998;  57 51-55
    Google Scholar
  • 45 Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy.  Pharmacol Ther. 1997;  74 207-220
    Google Scholar
  • 46 Nagai H. Effects of transplacentally injected alkylating agents upon development of embryos: appearance of intrauterine death and mesodermal malformation.  Bull Tokyo Dent Coll. 1972;  13 103-119
    Google Scholar
  • 47 Nettleton J, Long J, Kuban D. et al . Breast cancer during pregnancy: quantifying the risk of treatment delay.  Obstet Gynecol. 1996;  87 414-418
    Google Scholar
  • 48 Berry D L, Theriault R L, Holmes F A. et al . Management of breast cancer during pregnancy using a standardized protocol.  J Clin Oncol. 1999;  17 855-861
    Google Scholar
  • 49 Giacalone P L, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey.  Cancer. 1999;  86 2266-2272
    Google Scholar
  • 50 Reynoso E E, Shepherd F A, Messner H A. et al . Acute leukemia during pregnancy: the Toronto leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents.  J Clin Oncol. 1987;  5 1098-1106
    Google Scholar
  • 51 Garber J E. Long-term follow-up of the children exposed in utero to antineoplastic agents.  Seminars Oncol. 1989;  16 437-444
    Google Scholar
  • 52 Ebert U, Lofller H, Kirch W. Cytotoxic therapy anda pregnancy.  Pharmacol Ther. 1997;  74 207-220
    Google Scholar
  • 53 Nicholson H O. Leukemia and pregnancy. A report of five cases and discussion of management.  J Obstet Gynecol Br Commonw. 1968;  75 517-520
    Google Scholar
  • 54 Williams S F, Schilsky R L. Antineoplastic drugs administered during pregnancy.  Semin Oncol. 2000;  27 618-622
    Google Scholar
  • 55 Barthelmes L, Davidson L A, Gaffney C. et al . Pregnancy and breast cancer.  BMJ. 2005;  330 1375-1378
    Google Scholar
  • 56 Moore H CF, Foster R S. Breast cancer and pregnancy.  Semin Oncol. 2000;  27 646-653
    Google Scholar
  • 57 Clark R M, Reid J. Carcinoma of the breast in pregnancy or lactation.  Int J Radiat Oncol Biol Phys. 1978;  4 693-698
    Google Scholar
  • 58 Clark R, Chua T. Breast cancer and pregnancy: The ultimate challange.  Clin Oncol. 1989;  1 11-18
    Google Scholar

Z. Hrgovic, MD, PhD

Kaiserstraße 15

60311 Frankfurt

Germany

Phone: ++ 49/69/29 30 00

Fax: ++ 49/69/29 16 97

Email: info@hrgovic.de

      >